2014
DOI: 10.2174/15701808113109990067
|View full text |Cite
|
Sign up to set email alerts
|

Prediction of the Estrogen Receptor Binding Affinity for both hER<sub>&#945;</sub> and hER<sub>&#946;</sub> by QSAR Approaches

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2015
2015
2021
2021

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…However, several of these compounds (Heptachlor [P89], Lindane [P108], Endrin [P110], and Thiodan [P113]) have structures that deviate significantly from established structure–activity relationship (SAR) characteristics reported for estrogenic chemicals . Although quantitative SAR (QSAR) models have been previously developed for both ERα and ERβ binding, SAR approaches alone are unlikely to anticipate binding of a novel compound to ERα/β, especially if the compound structure does not fall under the established classes of known estrogenic chemicals or tested compounds . Whether these novel ER activators directly bind to the ER ligand‐binding pocket and activate the ER and ER‐dependent gene expression by the classical mechanism or whether they use a more novel mechanism (i.e., allosteric modulation or stimulation of an ER‐activating kinase activity) remains to be determined.…”
Section: Resultsmentioning
confidence: 99%
“…However, several of these compounds (Heptachlor [P89], Lindane [P108], Endrin [P110], and Thiodan [P113]) have structures that deviate significantly from established structure–activity relationship (SAR) characteristics reported for estrogenic chemicals . Although quantitative SAR (QSAR) models have been previously developed for both ERα and ERβ binding, SAR approaches alone are unlikely to anticipate binding of a novel compound to ERα/β, especially if the compound structure does not fall under the established classes of known estrogenic chemicals or tested compounds . Whether these novel ER activators directly bind to the ER ligand‐binding pocket and activate the ER and ER‐dependent gene expression by the classical mechanism or whether they use a more novel mechanism (i.e., allosteric modulation or stimulation of an ER‐activating kinase activity) remains to be determined.…”
Section: Resultsmentioning
confidence: 99%
“…Quantitative structure-activity relationship (QSAR) modeling has been applied to develop estrogen receptor binding models in the past decade, as shown in Table 1 (Hong et al, 2002; Serafimova et al, 2007; Liu et al, 2008; Li and Gramatica, 2010; Taha et al, 2010; Vedani et al, 2012; Zang et al, 2013; Zhang et al, 2013, 2014; Deng et al, 2014; Ng et al, 2015). These studies have covered a wide range of modeling approaches and data set sizes, from a descriptor-based decision tree (Hong et al, 2002) to 3-D docking and multi-dimensional QSAR (Vedani et al, 2012).…”
Section: Introductionmentioning
confidence: 99%